A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

Name: A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
Published: 2026
License: Public Domain

Rocket Pharmaceuticals Inc. · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

cardiomyopathy genetherapy heartfailure

dilated cardiomyopathy (dcm), cardiomyopathy, dilated, bag3 protein, human, dilated cardiomyopathy, dcm, bag3, bcl2-associated athanogene 3, genetic cardiomyopathy, gene therapy, heart failure

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 908330
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.